Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential diagnosis of suspected multiple sclerosis: a consensus approach.
Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland HF, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH. Miller DH, et al. Among authors: reingold sc. Mult Scler. 2008 Nov;14(9):1157-74. doi: 10.1177/1352458508096878. Epub 2008 Sep 19. Mult Scler. 2008. PMID: 18805839 Free PMC article.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Fiest K, Reider N, Reingold S, Cohen JA; attendees of the International Workshop on Comorbidity in Multiple Sclerosis. Marrie RA, et al. Neurology. 2016 Apr 12;86(15):1446-1453. doi: 10.1212/WNL.0000000000002474. Epub 2016 Feb 10. Neurology. 2016. PMID: 26865523 Free PMC article.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Reingold S, Cohen JA; attendees of the International Workshop on Comorbidity in Multiple Sclerosis. Marrie RA, et al. Neurology. 2016 Apr 12;86(15):1437-1445. doi: 10.1212/WNL.0000000000002471. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888986 Free PMC article.
Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Goodkin DE, Reingold S, Sibley W, Wolinsky J, McFarland H, Cookfair D, Lublin F. Goodkin DE, et al. Ann Neurol. 1999 Jul;46(1):132-4. doi: 10.1002/1531-8249(199907)46:1<132::aid-ana22>3.0.co;2-z. Ann Neurol. 1999. PMID: 10401793 No abstract available.
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD; SPI2 investigative teams. Cree BAC, et al. Lancet Neurol. 2020 Dec;19(12):988-997. doi: 10.1016/S1474-4422(20)30347-1. Epub 2020 Oct 23. Lancet Neurol. 2020. PMID: 33222767 Clinical Trial.
70 results